| Шығарылым |
Атауы |
Файл |
| № 5 (2013) |
Phosphate-binder therapy: economical aspects |
|
|
Mikhailova N.
|
| № 2 (2011) |
Experimental models of renal tubulointersitial damade in arterial hypertension |
|
|
Arutyunov G., Sokolova A., Oganezova L.
|
| № 2 (2009) |
Experimental models of chronic nephropathies |
|
|
Paltseva E.
|
| Том 14, № 2 (2022) |
Expert judgement «Correction of hyperkalemia in CKD. Modern possibilities and therapeutic relevance» |
|
|
Mikhailova N.
|
| Том 14, № 3 (2022) |
Expert opinion. Low-protein high caloric enteral nutrition «Fresubin Renal» in nephrology |
|
|
Shutov E.
|
| Том 14, № 2 (2022) |
Expert Council «Therapy of mineral and bone disorders in CKD. Sevelamer carbonate: from control of hyperphosphatemia to pleiotropic effects» |
|
|
- -.
|
| № 3 (2018) |
Extracorporeal membrane oxygenation in life-threatening ANCA-positive diffuse necrotizing alveolar hemorrhage |
|
|
Lysenko M., Frolova N., Ketskalo M., Dyakova E., Sysoeva I., Zhilinskaya T., Kotenko O., Volgina G.
|
| Том 13, № 4 (2021) |
Endothelial dysfunction in patients with chronic kidney disease: prognostic potential of endothelin-1 |
|
|
Gasanov M., Panchenko M., Batyushin M., Bronovitskaya N., Razina A.
|
| № 2 (2018) |
Epigenetic regulation of renal fibrosis in diabetic nephropathy: focus on histone modifications |
|
|
Aitbaev K., Murkamilov I., Murkamilova Z., Fomin V.
|
| Том 14, № 2 (2022) |
Epidemiology of covid-19 in patients on renal replacement therapy in the Russian federation in 2021 (brief report) |
|
|
Shilov E., Shilova M., Rumyantseva E., Yesayan A., Kotenko O.
|
| Том 13, № 1 (2021) |
Epidemiology of COVID-19 in patients receiving renal replacement therapy in the Russian Federation: results of 2020 |
|
|
Shilov E., Kotenko O., Shilova M., Milchakov K., Rumyantseva E., Khalfin R.
|
| № 2 (2013) |
Arterial hypertension epidemiology: associations with renal involvement and salt-sensitivity phenomena |
|
|
Arutyunov G., Oganezova L., Dragunov D., Sokolova A.
|
| Том 11, № 3 (2019) |
Epidemiology of chronic kidney disease among residents of Moscow |
|
|
Dudko M., Kotenko O., Shutov E., Vasina N.
|
| № 1 (2010) |
ESSENTIAL ARTERIAL HYPERTENSION AND CHRONIC RENAL FAILURE IN PATIENTS WITH LONG-TERM FOLLOW-UP IN MULTIDISCIPLINARY OUTPATIENT HEALTH CARE FACILITY |
|
|
Alekseeva L., Popova L., Ryzhenkova I., Alekseeva L., Popova L., Ryzhenkova I.
|
| Том 12, № 2 (2020) |
Ethelcalcetide in the treatment of secondary hyperparathyroidism in hemodialysis patients: a review of clinical data and a place in therapy |
|
|
Volgina G., Mikhailova N.
|
| № 3 (2018) |
Effect of dialyzer with vitamin E on treatment of anemia and inflammation level |
|
|
Shutov E., Balkarova O., Kotlyarova G.
|
| Том 14, № 4 (2022) |
The effectiveness of hydroxychloroquine and its effect on cell-mediated and humoral immunity in patients with immunoglobulin A nephropathy: results of a prospective controlled study |
|
|
Komissarov K., Nizheharodava D., Minchenko E., Ivanchik G., Pilotovich V., Zafranskaya M.
|
| Том 14, № 2 (2022) |
Effectiveness and safety of SGLT-2 inhibitors for renal allograft recipients with post-transplant diabetes mellitus: an open single-center prospective study |
|
|
Novikova M., Allazova S., Molina L., Koteshkova O., Antsiferov M., Kotenko O., Shilov E.
|
| Том 12, № 3 (2020) |
The efficacy and safety of the sucroferric oxyhydroxide (Velphoro®) in hemodialysis patients: results of a prospective randomized controlled trial |
|
|
Shutov E., Kotlyarova G., Lysenko K., Ryabinskaya G., Lashutin S.
|
| № 2 (2019) |
Efficacy and safety of the first russian original long-acting erythropoiesis-stimulating agent for the treatment of anemia in patients with chronic renal failure. The results of the international multicenter randomized phase II clinical trial |
|
|
Shilo V., Alihanova L., Babich V., Vishnevskii K., Zhdanova I., Zuev A., Kalachik O., Kotova L., Legotin A., Sabodash A., Suchkov V., Timokhovskaia G., Toropilov D., Tutin A., Priluckij S., Fedotova L., Khadikova N., Morozova M., Bolsun D., Dokukina E., Linkova Y., Ivanov R.
|
| Том 13, № 2 (2021) |
Efficacy and safety of etelcalcetide compared with cinacalcet in patients received hemodialysis with secondary hyperparathyroidism. Results from a prospective randomized trial |
|
|
Shutov E., Kotlyarova G., Lysenko K., Ryabinskaya G., Lashutin S., Markelova I., Rubleva S.
|
| Том 15, № 2 (2023) |
Effectiveness of treatment with glucocorticosteroids in immunoglobulin A nephropathy with active proliferative histopatological changes |
|
|
Komissarov K., Krasko O., Minchenko E., Pilotovich V.
|
| № 5 (2011) |
SUCCESFUL RITUXIMAB THERAPY OF MEMBRANOUS NEPHROPATHY, RESISTANT TO STANDARD IMMUNOSUPRESSIVE TREATMENT |
|
|
Pulin A., Gornostaeva E., Roshchupkina S., Kozlovskaya L., Fomin V., Mukhin N.
|
| № 3 (2013) |
Modification of diet efficacy in renal transplant recipients |
|
|
Zuglova E.
|
| № 4 (2009) |
IS THE ALCOHOL CONSUMPTION THE RISK FACTOR FOR CHRONIC KIDNEY DISEASE? |
|
|
- -.
|
| Нәтижелер 925 - 901/925 |
<< < 1 2 3 4 5 6 7 8 9 10 |
